Zobrazeno 1 - 9
of 9
pro vyhledávání: '"P. V. Grundler"'
Autor:
C. Favaretto, P. V. Grundler, Z. Talip, U. Köster, K. Johnston, S. D. Busslinger, P. Sprung, C. C. Hillhouse, R. Eichler, R. Schibli, C. Müller, N. P. van der Meulen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Terbium-149 (T1/2 = 4.1 h, Eα = 3.98 MeV (16.7%), 28 µm range in tissue) is a radionuclide with potential for targeted alpha therapy. Due to the negligible emission of α-emitting daughter nuclides, toxicity to healthy tissue may be reduce
Externí odkaz:
https://doaj.org/article/f90309a351d0488db47f6019295a5642
Autor:
C. Favaretto, Z. Talip, F. Borgna, P. V. Grundler, G. Dellepiane, A. Sommerhalder, H. Zhang, R. Schibli, S. Braccini, C. Müller, N. P. van der Meulen
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-17 (2021)
Abstract Background Terbium-155 [T1/2 = 5.32 d, Eγ = 87 keV (32%) 105 keV (25%)] is an interesting radionuclide suitable for single photon emission computed tomography (SPECT) imaging with potential application in the diagnosis of oncological diseas
Externí odkaz:
https://doaj.org/article/6ebd72eb03ab44f6b53081c7ebb3a98e
Autor:
Frédéric Juget, Zeynep Talip, Youcef Nedjadi, M. Teresa Durán, Pascal V. Grundler, Jan Rijn Zeevaart, Nicholas P. van der Meulen, Claude Bailat
Publikováno v:
EJNMMI Physics, Vol 9, Iss 1, Pp 1-18 (2022)
Abstract Background 161Tb draws an increasing interest in nuclear medicine for therapeutic applications. More than 99% of the emitted gamma and X-rays of 161Tb have an energy below 100 keV. Consequently, precise activity measurement of 161Tb becomes
Externí odkaz:
https://doaj.org/article/687b6810802745069ee68742726a9d6f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Francesca Borgna, Patrick Barritt, Pascal V. Grundler, Zeynep Talip, Susan Cohrs, Jan Rijn Zeevaart, Ulli Köster, Roger Schibli, Nicholas P. van der Meulen, Cristina Müller
Publikováno v:
Pharmaceutics, Vol 13, Iss 4, p 536 (2021)
The decay of terbium-161 results in the emission of β¯-particles as well as conversion and Auger electrons, which makes terbium-161 interesting for therapeutic purposes. The aim of this study was to use dual-isotope SPECT imaging in order to demons
Externí odkaz:
https://doaj.org/article/5d0e012b9f744ee4ad5cef2e055a967c
Autor:
Nicholas P. van der Meulen, Roger Hasler, Zeynep Talip, Pascal V. Grundler, Chiara Favaretto, Christoph A. Umbricht, Cristina Müller, Gaia Dellepiane, Tommaso S. Carzaniga, Saverio Braccini
Publikováno v:
Molecules, Vol 25, Iss 20, p 4706 (2020)
44Sc has favorable properties for cancer diagnosis using Positron Emission Tomography (PET) making it a promising candidate for application in nuclear medicine. The implementation of its production with existing compact medical cyclotrons would mean
Externí odkaz:
https://doaj.org/article/3e81b20a86f14bc3b6cdb85758f0bd4e
Autor:
Darja Beyer, Christian Vaccarin, Xavier Deupi, Ana Katrina Mapanao, Susan Cohrs, Fan Sozzi-Guo, Pascal V. Grundler, Nicholas P. van der Meulen, Jinling Wang, Matthias Tanriver, Jeffrey W. Bode, Roger Schibli, Cristina Müller
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Purpose The angiotensin converting enzyme-2 (ACE2)—entry receptor of SARS-CoV-2—and its homologue, the angiotensin-converting enzyme (ACE), play a pivotal role in maintaining cardiovascular homeostasis. Potential changes in ACE2 expressi
Externí odkaz:
https://doaj.org/article/ad4f974295474f0392325fbd07ff6ab8
Autor:
Pascal V. Grundler, Robert Eichler, Zeynep Talip, P. August Schubiger, Roger Schibli, Nicholas P. van der Meulen
Publikováno v:
CHIMIA, Vol 74, Iss 12, Pp 968-975 (2020)
Radionuclide production and development has a long history at the Paul Scherrer Institute (PSI) and dates back to the founding times of its forerunner institutions: the Federal Institute for Reactor Research and the Swiss Institute for Nuclear Resear
Externí odkaz:
https://doaj.org/article/d50a69f001c64bf1bdb7a69870943663
Autor:
Frederic Juget, Teresa Durán, Youcef Nedjadi, Zeynep Talip, Pascal V. Grundler, Chiara Favaretto, Pierluigi Casolaro, Gaia Dellepiane, Saverio Braccini, Claude Bailat, Nicholas P. van der Meulen
Publikováno v:
Molecules, Vol 28, Iss 3, p 1345 (2023)
44Sc is a promising radionuclide for positron emission tomography (PET) in nuclear medicine. As a part of the implementation of a production site for 44Sc, precise knowledge of the activity of the product is necessary. At the Paul Scherrer Institute
Externí odkaz:
https://doaj.org/article/a13e01e0590844e4bb5f1117ecec2bd5